| 26 | 6YL9 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide |
OXB |
 |
SHOW |
| 27 | 6T05 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
2-(phenylmethyl)imidazolidine |
M6H |
 |
SHOW |
| 28 | 6T0A |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
(~{R})-azanyl(pyridin-3-yl)methanethiol |
M58 |
 |
SHOW |
| 29 | 6SYZ |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
~{N}-methylthieno[3,2-d]pyrimidin-4-amine |
M1E |
 |
SHOW |
| 30 | 6T07 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
~{N}-[(2~{S})-pyrrolidin-2-yl]-1~{H}-1,2,4-triazol-5-amine |
M45 |
 |
SHOW |
| 31 | 6SZ3 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
~{N}-methyl-5,6,7,8-tetrahydroquinolin-4-amine |
M1H |
 |
SHOW |
| 32 | 6YNO |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
6-[[methyl-[(1-phenylpyrazol-3-yl)methyl]amino]methyl]-1~{H}-pyrimidine-2,4-dione |
P0W |
 |
SHOW |
| 33 | 6YL8 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
(2~{R},5~{S})-2-(2-chlorophenyl)-5-methyl-morpholine |
OWZ |
 |
SHOW |
| 34 | 6SZ1 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
~{N}-methylquinazolin-4-amine |
M0W |
 |
SHOW |
| 35 | 6T01 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
6-methyl-5-nitro-4-phenyl-1~{H}-pyrimidin-2-one |
M4B |
 |
SHOW |
| 36 | 6SZ7 |
YTH domain-containing protein 1 | Homo sapiens |
Q96MU7 (YTDC1_HUMAN) |
5,6,7,8-tetrahydro-4~{a}~{H}-quinazoline-2,4-dione |
M1Q |
 |
SHOW |
| 37 | 3AX7 |
Xanthine dehydrogenase/oxidase | Bos taurus |
P80457 (XDH_BOVIN) |
2-HYDROXYBENZOIC ACID |
SAL |
 |
SHOW |
| 38 | 3NVW |
Xanthine dehydrogenase/oxidase | Bos taurus |
P80457 (XDH_BOVIN) |
GUANINE |
GUN |
 |
SHOW |
| 39 | 3NVY |
Xanthine dehydrogenase/oxidase | Bos taurus |
P80457 (XDH_BOVIN) |
3,5,7,3',4'-PENTAHYDROXYFLAVONE |
QUE |
 |
SHOW |
| 40 | 5M5G |
WD_REPEATS_REGION domain-containing protein | Chaetomium thermophilum |
G0S8H7 (G0S8H7_CHATD) |
N-TRIMETHYLLYSINE |
M3L |
 |
SHOW |
| 41 | 5KKL |
WD_REPEATS_REGION domain-containing protein | Chaetomium thermophilum |
G0S8H7 (G0S8H7_CHATD) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 42 | 5KJH |
WD_REPEATS_REGION domain-containing protein | Chaetomium thermophilum |
G0S8H7 (G0S8H7_CHATD) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 43 | 5WFC |
WD_REPEATS_REGION domain-containing protein | Chaetomium thermophilum |
G0S8H7 (G0S8H7_CHATD) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 44 | 4YFY |
VioF N-formyltransferase | Providencia alcalifaciens |
M9P0Q2 (M9P0Q2_9GAMM) |
dTDP-4-amino-4,6-dideoxyglucose |
0FX |
 |
SHOW |
| 45 | 2AJZ |
Vh gene product | Mus musculus |
A2NUE8 (A2NUE8_MOUSE) |
3-HYDROXY-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER |
ECG |
 |
SHOW |
| 46 | 2V88 |
V(D)J recombination-activating protein 2 | Mus musculus |
P21784 (RAG2_MOUSE) |
N-DIMETHYL-LYSINE |
MLY |
 |
SHOW |
| 47 | 2V87 |
V(D)J recombination-activating protein 2 | Mus musculus |
P21784 (RAG2_MOUSE) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 48 | 2V86 |
V(D)J recombination-activating protein 2 | Mus musculus |
P21784 (RAG2_MOUSE) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 49 | 2V83 |
V(D)J recombination-activating protein 2 | Mus musculus |
P21784 (RAG2_MOUSE) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |
| 50 | 2V85 |
V(D)J recombination-activating protein 2 | Mus musculus |
P21784 (RAG2_MOUSE) |
N-TRIMETHYLLYSINE |
M3L |
|
SHOW |